ABOUT 
SPECIALTY CARE
Nephrology Lecture 2024: Recent Advances in Chronic Kidney Disease Management
Updated: 08/22/24
Watch the Recorded Talk and Q&A
22 minutes total (Minute 00:27 to 00:49 of Spring 2024 regional meeting recording)
Presented April 11, 2024, Ann Arbor, MI
Presented by MCT2D Nephrology Lead, Dr. Michael Heung, Associate Professor of Medicine, Division of Nephrology, University of Michigan.
Learning Objectives
1. Describe recent literature expanding indications for SGLT2i in patients with CKD
2. Describe indications for non-selective MRA use
3. Describe the potential emerging role of GLP-1 receptor agonists
Download Dr. Heung's April 2024 slides (PDF)Tags: Created By MCT2D, Video, For Providers, Nephrology
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.